Largest biotech companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Amgen leads the 21 biotech companies ranked by revenue, at ZAR 634.8B, ahead of Gilead Sciences (ZAR 508.6B) and Biogen (ZAR 170.8B). Figures as of 18 Nov 2026, 23:05 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 21
- First
- AmgenZAR 634.8B
- Median
- ZAR 21B
- Combined market value
- ZAR 14.45T
- Countries
- 5
- Not ranked
- 3no revenue on file
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Revenue ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | AmgenAMGN · Health Care | ZAR 634.8B | ZAR 4.15T | ZAR 7,667.27 | 3.07% down | 34% up | ||
| 2 | Gilead SciencesGILD · Health Care | ZAR 508.6B | ZAR 3.62T | ZAR 2,918.77 | 0.75% down | 33% up | ||
| 3 | BiogenBIIB · Health Care | ZAR 170.8B | ZAR 641.9B | ZAR 4,342.58 | 0.25% up | 49% up | ||
| 4 | argenxARGX · Health Care | ZAR 71.7B | ZAR 1.02T | ZAR 16,258.12 | 0.66% down | 4% up | ||
| 5 | BioNTechBNTX · Health Care | ZAR 55B | ZAR 356.6B | ZAR 1,438.14 | 1.89% down | 16% down | ||
| 6 | Neurocrine BiosciencesNBIX · Health Care | ZAR 49.4B | ZAR 284.7B | ZAR 2,813.06 | 1.84% down | 20% up | ||
| 7 | ExelixisEXEL · Health Care | ZAR 40.1B | ZAR 287.8B | ZAR 1,179.57 | 0.31% down | 63% up | ||
| 8 | QiagenQGEN · Health Care | ZAR 36.1B | ZAR 176.8B | ZAR 856.04 | 0.38% down | 12% up | ||
| 9 | ModernaMRNA · Health Care | ZAR 33.6B | ZAR 1.38T | ZAR 3,399.13 | 4.84% down | 755% up | ||
| 10 | Halozyme TherapeuticsHALO · Health Care | ZAR 24.1B | ZAR 188.7B | ZAR 1,654.74 | 0.18% down | 37% up | ||
| 11 | Bio-TechneTECH · Health Care | ZAR 21B | ZAR 197.4B | ZAR 1,256.60 | 0.17% up | 26% up | ||
| 12 | RepligenRGEN · Health Care | ZAR 12.8B | ZAR 190.7B | ZAR 2,982.51 | 6.47% up | 5% up | ||
| 13 | Krystal BiotechKRYS · Health Care | ZAR 6.7B | ZAR 161.4B | ZAR 5,446.84 | 5.62% up | 46% up | ||
| 14 | Twist BioscienceTWST · Health Care | ZAR 6.5B | ZAR 137B | ZAR 2,009.70 | 3.88% up | 340% up | ||
| 15 | Adaptive BiotechnologiesADPT · Health Care | ZAR 4.8B | ZAR 79.6B | ZAR 491.59 | 0.11% down | 88% up | ||
| 16 | ImmunityBioIBRX · Health Care | ZAR 2B | ZAR 123.1B | ZAR 115.73 | 7.03% up | 193% up | ||
| 17 | Kymera TherapeuticsKYMR · Health Care | ZAR 677.3M | ZAR 178.6B | ZAR 2,092.27 | 0.32% down | 87% up | ||
| 18 | CG OncologyCGON · Health Care | ZAR 69.8M | ZAR 123.4B | ZAR 1,381.83 | 1.34% up | 85% up | ||
| 19 | CRISPR TherapeuticsCRSP · Health Care | ZAR 60.6M | ZAR 67.3B | ZAR 694.20 | 0.10% up | 21% down | ||
| 20 | Revolution MedicinesRVMD · Health Care | ZAR 0 | ZAR 597.1B | ZAR 2,760.55 | 1.76% down | 131% up | ||
| 21 | Scholar Rock HoldingSRRK · Health Care | ZAR 0 | ZAR 101.2B | ZAR 829.10 | 6.48% up | 14% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2729 ZAR). 3 companies have no revenue on file and are not ranked here.
Questions and answers
Which biotech companies rank first by revenue?
Amgen (ZAR 634.8B), Gilead Sciences (ZAR 508.6B) and Biogen (ZAR 170.8B) are the top three of the 21 biotech companies ranked by revenue as of 18 Nov 2026, 23:05 UTC.
How many biotech companies are in this ranking?
21 are ranked by revenue. 3 more have no revenue on file and are left out rather than ranked at zero.
What are these biotech companies worth together?
The 21 biotech companies ranked by revenue have a combined market value of ZAR 14.45T as of 18 Nov 2026, 23:05 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest biotech companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.